Information Journal Paper
APA:
CopySHIEHMORTEZA, M., AHMADI, A., ABDOLLAHI, M., NAYEBPOUR, M., MOHAMMADI, M., HAMISHEHKAR, H., NAJAFI, A., PAZOKI, M., & MOJTAHEDZADEH, M.. (2011). RECOMBINANT HUMAN ERYTHROPOIETIN REDUCES PLASMINOGEN ACTIVATOR INHIBITOR AND AMELIORATES PRO-INFLAMMATORY RESPONSES FOLLOWING TRAUMA. DARU JOURNAL OF PHARMACEUTICAL SCIENCE, 19(2), 159-165. SID. https://sid.ir/paper/275602/en
Vancouver:
CopySHIEHMORTEZA M., AHMADI A., ABDOLLAHI M., NAYEBPOUR M., MOHAMMADI M., HAMISHEHKAR H., NAJAFI A., PAZOKI M., MOJTAHEDZADEH M.. RECOMBINANT HUMAN ERYTHROPOIETIN REDUCES PLASMINOGEN ACTIVATOR INHIBITOR AND AMELIORATES PRO-INFLAMMATORY RESPONSES FOLLOWING TRAUMA. DARU JOURNAL OF PHARMACEUTICAL SCIENCE[Internet]. 2011;19(2):159-165. Available from: https://sid.ir/paper/275602/en
IEEE:
CopyM. SHIEHMORTEZA, A. AHMADI, M. ABDOLLAHI, M. NAYEBPOUR, M. MOHAMMADI, H. HAMISHEHKAR, A. NAJAFI, M. PAZOKI, and M. MOJTAHEDZADEH, “RECOMBINANT HUMAN ERYTHROPOIETIN REDUCES PLASMINOGEN ACTIVATOR INHIBITOR AND AMELIORATES PRO-INFLAMMATORY RESPONSES FOLLOWING TRAUMA,” DARU JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 19, no. 2, pp. 159–165, 2011, [Online]. Available: https://sid.ir/paper/275602/en